Integrated Diagnostics Holdings plc (LON: IDHC)
London
· Delayed Price · Currency is GBP · Price in USD 0.416
-0.020 (-4.48%)
Jan 23, 2025, 1:49 PM BST
LON: IDHC Revenue
Integrated Diagnostics Holdings had revenue of 1.33B EGP in the quarter ending June 30, 2024, with 38.74% growth. This brings the company's revenue in the last twelve months to 4.75B, up 34.79% year-over-year. In the year 2023, Integrated Diagnostics Holdings had annual revenue of 4.12B with 14.35% growth.
Revenue (ttm)
4.75B EGP
Revenue Growth
+34.79%
P/S Ratio
2.64
Revenue / Employee
709.56K EGP
Employees
6,692
Market Cap
205.56M GBP
Revenue Chart
* This company reports financials in EGP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 4.12B | 517.46M | 14.35% |
| Dec 31, 2022 | 3.61B | -1.62B | -31.00% |
| Dec 31, 2021 | 5.22B | 2.57B | 96.69% |
| Dec 31, 2020 | 2.66B | 429.77M | 19.30% |
| Dec 31, 2019 | 2.23B | 305.04M | 15.88% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| GSK plc | 31.31B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| ConvaTec Group | 1.74B |
| Hikma Pharmaceuticals | 2.39B |
| HUTCHMED (China) | 483.31M |
| Oxford Nanopore Technologies | 167.75M |
Integrated Diagnostics Holdings News
- 2 months ago - Integrated Diagnostics Holdings PLC (LSE:IDHC) Q3 2024 Earnings Call Highlights: Strong Revenue ... - GuruFocus
- 2 months ago - Q3 2024 Integrated Diagnostics Holdings PLC Earnings Call Transcript - GuruFocus